| « Elan, Biogen launch Tysabri trial in oncology | Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R ... » |
Link: http://www.ad-hoc-news.de/Aktie/12717982/News/19417511/ELAN.html
Elan and Biogen Idec Initiate Ad-Hoc-News (Pressemitteilung), Germany - 19 hours ago VLA4 is also found on the surface of multiple myeloma cells and may be involved in their survival. 'We are excited to initiate the oncology clinical trial